EUVIMEDEUVIMED entdecken
Crossref

Design and conduct of a randomized controlled feeding trial in a residential setting with mitigation for COVID-19

Julia M W Wong, David S Ludwig, David B Allison, Navneet Baidwan, Lisa Bielak, Chia-Ying Chiu, Stephanie L Dickinson, Lilian Golzarri-Arroyo, Steven B Heymsfield, Lauren Holmes, Lisa T Jansen, Donna Lesperance und 6 weitere

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Julia M W Wong und 17 weiteren Autor:innen. Beteiligte Einrichtung: New Balance Foundation Obesity Prevention Center, Boston Children's Hospital, United States of America; Harvard Medical School, Boston, MA, United St…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Arnold Ventures LLC, New Balance Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evaluating effects of different macronutrient diets in randomized trials requires well defined infrastructure and rigorous methods to ensure intervention fidelity and adherence. METHODS: This controlled feeding study comprised two phases. During a Run-in phase (14-15 weeks), study participants (18-50 years, BMI, ≥27 kg/m2) consumed a very-low-carbohydrate (VLC) diet, with home delivery of prepared meals, at an energy level to promote 15 ± 3% weight loss. During a Residential phase (13 weeks), participants resided at a conference center. They received a eucaloric VLC diet for three weeks and then were randomized to isocaloric test diets for 10 weeks: VLC (5% energy from carbohydrate, 77% from fat), high-carbohydrate (HC)-Starch (57%, 25%; including 20% energy from refined grains), or HC-Sugar (57%, 25%; including 20% sugar). Outcomes included measures of body composition and energy expenditure, chronic disease risk factors, and variables pertaining to physiological mechanisms. Six cores provided infrastructure for implementing standardized protocols: Recruitment, Diet and Meal Production, Participant Support, Assessments, Regulatory Affairs and Data Management, and Statistics. The first participants were enrolled in May 2018. Participants residing at the conference center at the start of the COVID-19 pandemic completed the study, with each core implementing mitigation plans. RESULTS: Before early shutdown, 77 participants were randomized, and 70 completed the trial (65% of planned completion). Process measures indicated integrity to protocols for weighing menu items, within narrow tolerance limits, and participant adherence, assessed by direct observation and continuous glucose monitoring. CONCLUSION: Available data will inform future research, albeit with less statistical power than originally planned.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultBody CompositionDiet, Carbohydrate-RestrictedEnergy MetabolismResearch DesignSARS-CoV-2Weight LossRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Body compositionDietary interventionFeeding protocolIntervention fidelityMacronutrient compositionObesity

Autor:innen und Institutionen

  • New Balance Foundation Obesity Prevention Center, Boston Children's Hospital, United States of America; Harvard Medical School, Boston, MA, United States of America.
  • Indiana University School of Public Health, Bloomington, IN, United States of America.
  • Department of Health Services Administration, School of Health Professions, University of Alabama at Birmingham, United States of America.
  • New Balance Foundation Obesity Prevention Center, Boston Children's Hospital, United States of America.
  • Division of Pulmonary, Allergy, and Acute Critical Care, Department of Medicine, University of Alabama at Birmingham, United States of America.
  • Metabolism & Body Composition Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, United States of America.

Förderung

  • Arnold Ventures LLC
  • New Balance Foundation

Zitieren

APA

Wong, J. M. W., Ludwig, D. S., Allison, D. B., Baidwan, N., Bielak, L., Chiu, C. Y., Dickinson, S. L., Golzarri-Arroyo, L., Heymsfield, S. B., Holmes, L., Jansen, L. T., Lesperance, D., Mehta, T., Sandman, M., Steltz, S. K., Wong, W. W., Yu, S., & Ebbeling, C. B. (2024). Design and conduct of a randomized controlled feeding trial in a residential setting with mitigation for COVID-19. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107490

Vancouver

Wong JMW, Ludwig DS, Allison DB, Baidwan N, Bielak L, Chiu CY, et al. Design and conduct of a randomized controlled feeding trial in a residential setting with mitigation for COVID-19. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107490

BibTeX
@article{Wong2024,
  author = {Wong, Julia M W and Ludwig, David S and Allison, David B and Baidwan, Navneet and Bielak, Lisa and Chiu, Chia-Ying and Dickinson, Stephanie L and Golzarri-Arroyo, Lilian and Heymsfield, Steven B and Holmes, Lauren and Jansen, Lisa T and Lesperance, Donna and Mehta, Tapan and Sandman, Megan and Steltz, Sarah K and Wong, William W and Yu, Shui and Ebbeling, Cara B},
  title = {Design and conduct of a randomized controlled feeding trial in a residential setting with mitigation for COVID-19},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107490}
}
Kostenlos starten →